Infliximab-induced pityriasis lichenoides chronica in a patient with psoriasis

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 2, 2009, Pages 230-231

  Newell, E L ^a   Jain, S ^b   Stephens, C ^b   Martland, G ^b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB;

ADULT; ANAMNESIS; BLOOD EXAMINATION; CASE REPORT; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; LETTER; MALE; PITYRIASIS; PITYRIASIS LICHENOIDES; PRIORITY JOURNAL; PSORIASIS; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; HUMANS; MALE; MIDDLE AGED; PITYRIASIS LICHENOIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58449096411     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02818.x     Document Type: Letter

References (6)

1. Winterfield LS, Menter A. Infliximab. Dermatol Ther 2004 17 : 409 426.
2. Lee HH, Song IH, Friedrich M et al. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-α antagonists. Br J Dermatol 2007 156 : 486 491.
3. Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A. Psoriasis induced by anti-tumour necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum 2005 52 : 2513 2518.
4. Kary S, Worm M, Audring H et al. New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists. Ann Rheum Dis 2006 65 : 405 407.
5. de Gannes GC, Ghoreshi M, Pope J et al. Psoriasis and pustular dermatitis triggered by TNF-α inhibitors in patients with rheumatologic conditions. Arch Dermatol 2007 143 : 223 231.
6. Chustecka Z. Psoriasis with TNF inhibitors: is there an infectious aetiology? Available from : http://www.medscape.com/viewarticle/538352